Hemorrhagic Fever News and Research

RSS
Viral hemorrhagic fevers (VHFs) refer to a group of illnesses that are caused by several distinct families of viruses. In general, the term "viral hemorrhagic fever" is used to describe a severe multisystem syndrome (multisystem in that multiple organ systems in the body are affected). Characteristically, the overall vascular system is damaged, and the body's ability to regulate itself is impaired. These symptoms are often accompanied by hemorrhage (bleeding); however, the bleeding is itself rarely life-threatening. While some types of hemorrhagic fever viruses can cause relatively mild illnesses, many of these viruses cause severe, life-threatening disease.
Second round of Ebola vaccination trials on the way to DRC

Second round of Ebola vaccination trials on the way to DRC

Mutations in specific protein make dengue virus resistant to vaccines and therapeutics

Mutations in specific protein make dengue virus resistant to vaccines and therapeutics

Researchers analyze people’s initial immune response to dengue fever

Researchers analyze people’s initial immune response to dengue fever

Promising new strategy to treat severe dengue disease on the horizon

Promising new strategy to treat severe dengue disease on the horizon

Studying human behavior might help curb mosquito-borne illness

Studying human behavior might help curb mosquito-borne illness

WHO declares the deadly Ebola outbreak in Congo a global health emergency

WHO declares the deadly Ebola outbreak in Congo a global health emergency

Developing new immunotherapeutic treatments for emerging viral diseases

Developing new immunotherapeutic treatments for emerging viral diseases

Ebola spread to Uganda could threaten international health

Ebola spread to Uganda could threaten international health

New study suggests bacteria-loaded mosquitoes may halt spread of Dengue fever

New study suggests bacteria-loaded mosquitoes may halt spread of Dengue fever

FDA approves first vaccine for prevention of dengue disease in endemic regions

FDA approves first vaccine for prevention of dengue disease in endemic regions

UTMB receives grant to combat highly-lethal hemorrhagic fever viruses

UTMB receives grant to combat highly-lethal hemorrhagic fever viruses

NIAID awards $22 million grant to develop antibody-based therapies against lethal viruses

NIAID awards $22 million grant to develop antibody-based therapies against lethal viruses

Study uncovers details about human immune response to dengue infection

Study uncovers details about human immune response to dengue infection

Staten Island severely infested with self-cloning Asian longhorned ticks

Staten Island severely infested with self-cloning Asian longhorned ticks

Researchers unravel biomechanics of Ebola virus-host cell adhesion

Researchers unravel biomechanics of Ebola virus-host cell adhesion

New sensing tool could aid in early detection of Dengue virus

New sensing tool could aid in early detection of Dengue virus

Disease X: an unknown disease that could claim millions of lives

Disease X: an unknown disease that could claim millions of lives

Researchers uncover new mechanism of how Ebola viruses escape immune system

Researchers uncover new mechanism of how Ebola viruses escape immune system

NIAID-funded clinical trial of Ebola vaccines is underway at Cincinnati Children's

NIAID-funded clinical trial of Ebola vaccines is underway at Cincinnati Children's

Scientists solve another piece of Ebola virus puzzle

Scientists solve another piece of Ebola virus puzzle

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.